Assisted Reproductive Technology Market Size Grows at a CAGR of 10.95%

Introduction

Straits Research released its highly anticipated report, “Global Assisted Reproductive Technology Market Size & Outlook, 2026-2034”. According to the study, the global market size is valued at USD 31.63 billion in 2025 and is projected to expand to USD 80.58 billion by 2034, registering a compound annual growth rate (CAGR) of 10.95%.

Market Dynamics

The growth of the global assisted reproductive technology market is primarily fueled by rising infertility rates and significant societal shifts influencing family planning behaviors. Increasing urbanization, delayed marriages, stressful lifestyles, obesity, and declining sperm quality are major contributors to the growing incidence of infertility worldwide. According to the World Health Organization (WHO, 2023), infertility affects approximately one in six individuals globally, underscoring the critical role of ART in supporting reproductive health. The expanding acceptance of fertility treatments among diverse demographics, including single parents and same-sex couples, is further broadening the patient base and driving market expansion.

Furthermore, advancements in automation and remote technologies are revolutionizing ART procedures by enhancing accuracy, minimizing manual errors, and increasing treatment efficiency. For instance, in April 2025, Conceivable Life Sciences announced the world’s first birth through a fully automated, AI-controlled ICSI technology at Hope IVF Mexico, marking a transformative milestone in fertility care. These technological innovations also promote accessibility through telemedicine platforms, allowing fertility clinics to extend their reach to remote and underserved areas, thereby reducing geographical and financial barriers for patients. However, the market faces challenges such as the high cost of ART procedures, which continues to limit affordability in low-income regions. Despite these restraints, the growing use of digital monitoring tools is creating new opportunities for improved success rates and patient-centered fertility services.

Market Highlights

• Procedure: The artificial insemination segment is projected to register a CAGR of 12.16% during the forecast period.
• Technology: The instruments and equipment segment dominated the market with a revenue share of 37.52%, in 2025.
• End User: The hospitals and other medical settings is estimated to grow at the fastest CAGR of 11.47%.
• Regional Insights: Europe dominated the market with a revenue share of 39.78% in 2025, owing to a surge in demand for ART procedures.

Competitive Players

1. CooperSurgical
2. Ferring Pharmaceuticals
3. Hamilton Thorne
4. Vitrolife
5. Genea
6. California Cryobank
7. European Sperm Bank
8. INVO Bioscience
9. Monash IVF Group
10. Progyny
11. Microm
12. OvaScience
13. Bloom IVF Centre
14. Virtus Health
15. IVI RMA Global
16. New Hope Fertility Center
17. CCRM Fertility
18. Sher Fertility Institute
19. Others

Recent Developments

Segmentation

1. By Procedure (2026-2034)
   1. In-Vitro Fertilization
      1. Fresh Non-Donor
      2. Frozen Non-Donor
      3. Fresh Donor
      4. Frozen Donor
   2. Artificial Insemination
      1. Intravaginal
      2. Intrauterine
      3. Intracervical
      4. Intratubal
2. By Technology (2026-2034)
   1. Instruments & Equipment
   2. Software & AI Solutions
   3. Accessories & Disposables
   4. Culture Media
3. By End User (2026-2034)
   1. Fertility Clinics & Specialized Facilities
   2. Hospitals & Other Medical Settings